Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-γ activators (Q45586468)

14 December 2017

title

Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-γ activators (English)

1 reference

14 December 2017

Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-γ activators (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

15 July 2024

Bharat Raj Bhattarai

1 reference

14 December 2017

Bhooshan Kafle

1 reference

14 December 2017

Ji-Sun Hwang

1 reference

14 December 2017

Seung Wook Ham

1 reference

14 December 2017

Keun-Hyeung Lee

1 reference

14 December 2017

Hwangseo Park

1 reference

14 December 2017

Inn-Oc Han

1 reference

14 December 2017

Hyeongjin Cho

1 reference

14 December 2017

language of work or name

English

0 references

publication date

17 September 2010

1 reference

full work available at URL

14 December 2017

1 reference

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0960894X10012667?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

https://api.elsevier.com/content/article/PII:S0960894X10012667?httpAccept=text/plain

15 July 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Bioorganic & Medicinal Chemistry Letters

15 July 2024

published in

1 reference

14 December 2017

1 reference

14 December 2017

1 reference

14 December 2017

page(s)

6758-6763

1 reference

Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Thiazolidinediones: a new class of antidiabetic drugs

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Metformin: a useful adjunct to insulin therapy?

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

PTP1B regulates leptin signal transduction in vivo

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

PTP1B: from the sidelines to the front lines!

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

PTP1B as a drug target: recent developments in PTP1B inhibitor discovery

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B.

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Design, synthesis, and conformational dynamics of a gated molecular basket

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Structural and evolutionary relationships among protein tyrosine phosphatase domains

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as PTP1B inhibitors with hypoglycemic activity

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.130

15 July 2024

Identifiers

1 reference

14 December 2017

1 reference